{ "company_number": "06981865", "name": "Unicorn Pharmaceutics Ltd", "url": "/company/06981865", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2009-08-05", "dissolved_on": null, "sic_codes": [ { "code": "86900", "description": "Other human health activities", "section": "Q", "section_name": "Human health and social work activities", "url": "/sic/86900" } ], "registered_address": { "id": 2581338, "url": "/address/2581338", "line1": "213 CHISLEHURST ROAD", "line2": "", "post_town": "PETTS WOOD", "county": "KENT", "country": "ENGLAND", "postcode": "BR5 1NP" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/06981865", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-05-31", "last_made_up": "2025-08-31", "category": "UNAUDITED ABRIDGED", "filings": [ { "url": "/company/06981865/accounts/2025-08-31", "pdf_url": "/company/06981865/accounts/2025-08-31.pdf", "made_up_date": "2025-08-31", "period_start": "2025-08-31", "period_end": "2025-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": null, "debtors": "13052.00", "cash_bank_in_hand": "1112.00", "current_assets": "14164.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "5437.00", "total_assets_less_current_liabilities": "5437.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Bulk_Data-2026-06-02.zip" }, { "url": "/company/06981865/accounts/2024-08-31", "pdf_url": "/company/06981865/accounts/2024-08-31.pdf", "made_up_date": "2024-08-31", "period_start": "2024-08-31", "period_end": "2024-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "18390.00", "current_assets": "18390.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "5665.00", "total_assets_less_current_liabilities": "5665.00", "net_assets_liabilities": "5665.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2025.zip" }, { "url": "/company/06981865/accounts/2023-08-31", "pdf_url": "/company/06981865/accounts/2023-08-31.pdf", "made_up_date": "2023-08-31", "period_start": "2023-08-31", "period_end": "2023-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "3304.00", "debtors": "37160.00", "cash_bank_in_hand": "6043.00", "current_assets": "43203.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "36958.00", "total_assets_less_current_liabilities": "40262.00", "net_assets_liabilities": "639.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2024.zip" }, { "url": "/company/06981865/accounts/2022-08-31", "pdf_url": "/company/06981865/accounts/2022-08-31.pdf", "made_up_date": "2022-08-31", "period_start": "2022-08-31", "period_end": "2022-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "7006.00", "debtors": "23176.00", "cash_bank_in_hand": "18015.00", "current_assets": "41191.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "36753.00", "total_assets_less_current_liabilities": "43759.00", "net_assets_liabilities": "428.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2023.zip" }, { "url": "/company/06981865/accounts/2021-08-31", "pdf_url": "/company/06981865/accounts/2021-08-31.pdf", "made_up_date": "2021-08-31", "period_start": "2021-08-31", "period_end": "2021-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": "3.00", "tangible_fixed_assets": "10708.00", "debtors": "46625.00", "cash_bank_in_hand": "32914.00", "current_assets": "79539.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "61984.00", "total_assets_less_current_liabilities": "72692.00", "net_assets_liabilities": "22692.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2022.zip" }, { "url": "/company/06981865/accounts/2020-08-31", "pdf_url": "/company/06981865/accounts/2020-08-31.pdf", "made_up_date": "2020-08-31", "period_start": "2020-08-31", "period_end": "2020-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "1544.00", "debtors": null, "cash_bank_in_hand": "65216.00", "current_assets": "65216.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "44376.00", "total_assets_less_current_liabilities": "45920.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2021.zip" }, { "url": "/company/06981865/accounts/2019-08-31", "pdf_url": "/company/06981865/accounts/2019-08-31.pdf", "made_up_date": "2019-08-31", "period_start": "2019-08-31", "period_end": "2019-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "2673.00", "debtors": null, "cash_bank_in_hand": "66154.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "33325.00", "total_assets_less_current_liabilities": "35998.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-June2020.zip" }, { "url": "/company/06981865/accounts/2018-08-31", "pdf_url": "/company/06981865/accounts/2018-08-31.pdf", "made_up_date": "2018-08-31", "period_start": "2018-08-31", "period_end": "2018-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": "1.00", "tangible_fixed_assets": "1602.00", "debtors": null, "cash_bank_in_hand": "35543.00", "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-697.00", "total_assets_less_current_liabilities": "905.00", "net_assets_liabilities": null, "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2019.zip" }, { "url": "/company/06981865/accounts/2017-08-31", "pdf_url": "/company/06981865/accounts/2017-08-31.pdf", "made_up_date": "2017-08-31", "period_start": "2017-08-31", "period_end": "2017-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "288.00", "debtors": null, "cash_bank_in_hand": "22864.00", "current_assets": "22864.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "423.00", "total_assets_less_current_liabilities": "711.00", "net_assets_liabilities": "711.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "611.00", "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-April2018.zip" }, { "url": "/company/06981865/accounts/2016-08-31", "pdf_url": "/company/06981865/accounts/2016-08-31.pdf", "made_up_date": "2016-08-31", "period_start": "2016-08-31", "period_end": "2016-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "384.00", "debtors": "277.00", "cash_bank_in_hand": "22403.00", "current_assets": "22680.00", "creditors_due_within_one_year": "22407.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "273.00", "total_assets_less_current_liabilities": "657.00", "net_assets_liabilities": null, "called_up_share_capital": "100.00", "profit_loss_account_reserve": "557.00", "shareholder_funds": "657.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2016.zip" }, { "url": "/company/06981865/accounts/2015-08-31", "pdf_url": "/company/06981865/accounts/2015-08-31.pdf", "made_up_date": "2015-08-31", "period_start": "2015-08-31", "period_end": "2015-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "512.00", "debtors": "278.00", "cash_bank_in_hand": "7921.00", "current_assets": "8199.00", "creditors_due_within_one_year": "3835.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "4364.00", "total_assets_less_current_liabilities": "4876.00", "net_assets_liabilities": null, "called_up_share_capital": "100.00", "profit_loss_account_reserve": "4776.00", "shareholder_funds": "4876.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2016.zip" }, { "url": "/company/06981865/accounts/2014-08-31", "pdf_url": "/company/06981865/accounts/2014-08-31.pdf", "made_up_date": "2014-08-31", "period_start": "2014-08-31", "period_end": "2014-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "682.00", "debtors": "278.00", "cash_bank_in_hand": "13682.00", "current_assets": "13960.00", "creditors_due_within_one_year": "4835.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "9125.00", "total_assets_less_current_liabilities": "9807.00", "net_assets_liabilities": null, "called_up_share_capital": "100.00", "profit_loss_account_reserve": "9707.00", "shareholder_funds": "9807.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2015.zip" }, { "url": "/company/06981865/accounts/2013-08-31", "pdf_url": "/company/06981865/accounts/2013-08-31.pdf", "made_up_date": "2013-08-31", "period_start": "2013-08-31", "period_end": "2013-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "910.00", "debtors": "278.00", "cash_bank_in_hand": "8848.00", "current_assets": "9126.00", "creditors_due_within_one_year": "5417.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3709.00", "total_assets_less_current_liabilities": "4619.00", "net_assets_liabilities": null, "called_up_share_capital": "100.00", "profit_loss_account_reserve": "4519.00", "shareholder_funds": "4619.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2014.zip" }, { "url": "/company/06981865/accounts/2012-08-31", "pdf_url": "/company/06981865/accounts/2012-08-31.pdf", "made_up_date": "2012-08-31", "period_start": "2012-08-31", "period_end": "2012-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "574.00", "debtors": "278.00", "cash_bank_in_hand": "32677.00", "current_assets": "32955.00", "creditors_due_within_one_year": "29041.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3914.00", "total_assets_less_current_liabilities": "4488.00", "net_assets_liabilities": null, "called_up_share_capital": "100.00", "profit_loss_account_reserve": "4388.00", "shareholder_funds": "4488.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2013.zip" }, { "url": "/company/06981865/accounts/2011-08-31", "pdf_url": "/company/06981865/accounts/2011-08-31.pdf", "made_up_date": "2011-08-31", "period_start": "2011-08-31", "period_end": "2011-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "765.00", "debtors": "1371.00", "cash_bank_in_hand": "48776.00", "current_assets": "50147.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-636.00", "total_assets_less_current_liabilities": "129.00", "net_assets_liabilities": "129.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "29.00", "shareholder_funds": "129.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2012.zip" }, { "url": "/company/06981865/accounts/2010-08-31", "pdf_url": "/company/06981865/accounts/2010-08-31.pdf", "made_up_date": "2010-08-31", "period_start": "2010-08-31", "period_end": "2010-08-31", "entity_name": "Unicorn Pharmaceutics Ltd", "dormant": false, "average_employees": null, "tangible_fixed_assets": "1020.00", "debtors": "2388.00", "cash_bank_in_hand": "10345.00", "current_assets": "12733.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "1673.00", "total_assets_less_current_liabilities": "2693.00", "net_assets_liabilities": "2693.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "2593.00", "shareholder_funds": "2693.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-May2011.zip" } ], "pdf_only_filings": [], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/06981865/filing-history" }, "confirmation_statement": { "next_due": "2026-06-10", "last_made_up": "2025-05-27" }, "officers": [ { "name": "KAHAN, Barbara", "person_url": "/person/808", "role": "director", "appointed_on": "2009-08-05", "resigned_on": "2009-08-05", "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-09-09T07:52:06+00:00" }, { "name": "HABIB, Mohammed", "person_url": "/person/8090590", "role": "secretary", "appointed_on": "2009-08-05", "resigned_on": "2009-08-05", "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-09-09T07:52:06+00:00" }, { "name": "SALIM, Haifa", "person_url": "/person/8090589", "role": "secretary", "appointed_on": "2009-08-05", "resigned_on": "2015-02-04", "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-09-09T07:52:06+00:00" }, { "name": "TALEB, Hassan", "person_url": "/person/8090567", "role": "director", "appointed_on": "2015-02-04", "resigned_on": null, "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-09-09T07:52:06+00:00" }, { "name": "HABIB, Mohammed", "person_url": "/person/8090590", "role": "director", "appointed_on": "2009-08-05", "resigned_on": null, "nationality": "British", "occupation": "", "source": "stream", "retrieved_at": "2026-09-09T07:52:06+00:00" } ], "psc": [ { "name": "Mr Mohammed Habib", "kind": "individual-person-with-significant-control", "person_url": "/person/3455345", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent", "right-to-appoint-and-remove-directors", "significant-influence-or-control" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-09T05:59:12.582323+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }